ClinicalTrials.gov
ClinicalTrials.gov Menu

Taste Test of a New Formulation of Sildenafil (Revatio)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00768573
Recruitment Status : Completed
First Posted : October 8, 2008
Last Update Posted : April 28, 2015
Sponsor:
Information provided by (Responsible Party):
Pfizer

Brief Summary:
taste of formulation

Condition or disease Intervention/treatment
None Volunteer Drug: sildenafil

Detailed Description:
taste test None

Study Type : Observational
Actual Enrollment : 4 participants
Time Perspective: Prospective
Official Title: A Single-Blind Study In Healthy Adult Volunteers To Investigate The Palatability Of Different Oral Suspension Formulations Of Revatio®
Study Start Date : January 2008
Actual Primary Completion Date : January 2008
Actual Study Completion Date : January 2008

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
1. Taste test
Not Specified
Drug: sildenafil
Oral suspension of sildenafil.




Primary Outcome Measures :
  1. palatability (aroma, flavour texture and mouth feel) [ Time Frame: Duration of study. ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Healthy volunteers
Criteria

Inclusion Criteria:

  • Healthy

Exclusion Criteria:

  • History of hypersensitivity to test compounds or excipients.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00768573


Locations
United States, Massachusetts
Pfizer Investigational Site
Cambridge, Massachusetts, United States, 02140
Sponsors and Collaborators
Pfizer
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer

Additional Information:
Responsible Party: Pfizer
ClinicalTrials.gov Identifier: NCT00768573     History of Changes
Other Study ID Numbers: A1481257
First Posted: October 8, 2008    Key Record Dates
Last Update Posted: April 28, 2015
Last Verified: April 2015

Keywords provided by Pfizer:
taste test

Additional relevant MeSH terms:
Sildenafil Citrate
Vasodilator Agents
Phosphodiesterase 5 Inhibitors
Phosphodiesterase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Urological Agents